Anaptysbio (ANAB) EBT Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9,460.35% |
| 10 | Anaptysbio | 1.60 Bn | 1.31 Bn | - | -34.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.51% |
| Dec 31, 2025 | 386.21% |
| Sep 30, 2025 | 146.00% |
| Jun 30, 2025 | 17.28% |
| Mar 31, 2025 | 10.59% |
| Dec 31, 2024 | -118.07% |
| Sep 30, 2024 | 11.95% |
| Jun 30, 2024 | -17.08% |
| Mar 31, 2024 | -10.07% |
| Dec 31, 2023 | 648.32% |
| Sep 30, 2023 | -36.30% |
| Jun 30, 2023 | -49.28% |
| Mar 31, 2023 | -27.09% |
| Dec 31, 2022 | 28.80% |
| Sep 30, 2022 | -308.58% |
| Jun 30, 2022 | -6,121.91% |
| Mar 31, 2022 | -72.89% |
| Dec 31, 2021 | -192.40% |
| Sep 30, 2021 | 71.81% |
| Jun 30, 2021 | 98.01% |
| Mar 31, 2021 | -119.87% |
| Dec 31, 2020 | 265.87% |
| Sep 30, 2020 | 23.54% |
| Jun 30, 2020 | 10.30% |
| Mar 31, 2020 | 62.61% |
| Dec 31, 2019 | -18.03% |
| Sep 30, 2019 | -94.79% |
| Jun 30, 2019 | -76.40% |
| Mar 31, 2019 | -46.47% |
| Dec 31, 2018 | -154.76% |
| Sep 30, 2018 | -73.82% |
| Jun 30, 2018 | -401.95% |
| Mar 31, 2018 | -46.55% |
| Dec 31, 2017 | -105.36% |
| Sep 30, 2017 | -670.86% |
| Jun 30, 2017 | -220.74% |
| Mar 31, 2017 | -720.89% |